Atlas Trials

FM101 Safety, Tolerability, Efficacy Study in the Patients With Ocular Hypertension

Clinical trial NCT04585100 · UNKNOWN

Trial details

NCT number
NCT04585100
Sponsor
Future Medicine
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Ocular Hypertension
Start date
2020-10-07
Primary completion
2023-01-31
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.